京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21302号 / 医博第4391号 / 新制||医||1030(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 生田 宏一, 教授 椛島 健治, 教授 杉田 昌彦 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

The multifunctional signaling hub p62 is well recognized as a ubiquitin sensor and a selective autophagy receptor. As a ubiquitin sensor, p62 promotes NFκB activation by facilitating TRAF6 ubiquitination and aggregation. As a selective autophagy receptor, p62 sorts ubiquitinated substrates including p62 itself for lysosome-mediated degradation. p62 plays crucial roles in myriad cellular processes including DNA damage response, aging/senescence, infection and immunity, chronic inflammation, and cancerogenesis, dependent on or independent of autophagy. Targeting p62-mediated autophagy may represent a promising strategy for clinical interventions of different cancers. In this review, we summarize the transcriptional and post-translational regulation of p62, and its mechanistic roles in cancers, with the emphasis on its roles in regulation of DNA damage response and its connection to the cGAS-STING-mediated antitumor immune response, which is promising for cancer vaccine design.

Oncolytic viruses (OVs) are promising tumor-selective treatments, and the efficacy of OV therapies has been shown to depend heavily on the successful delivery and spread of these agents within the tumor mass to generate profound immunostimulatory effects. We have previously reported the potential of vanadium-based compounds such as vanadyl sulfate (VS) as immune-stimulatory enhancers of OV immunotherapy. These compounds, in conjunction with RNA-based OVs such as oncolytic VSVΔ51, improve viral spread and oncolysis, leading to long-term antitumor immunity and prolonged survival in resistant tumor models as previously reported. This effect is associated with a virus-induced antiviral type I IFN response shifting towards a type II IFN response. Here, the systemic impact and the relevant immunological changes following VS/VSVΔ51 combination therapy were investigated to understand the immunological mechanism of action leading to improved antitumor responses. We screened for the secretion of chemokines and cytokines in vivo to understand the mechanism of action regulating the recruitment of immune cells to the tumor in the CT26WT tumor model following treatment. Additionally, the antigen-specific immune response was investigated to further identify the relevant immunological changes following treatment with the VS+VSVΔ51 combination. Our data revealed that VS+VSVΔ51 combination therapy significantly increased the levels of IFN-γ and IL-6, and other key important pro-inflammatory cytokines and chemokines. Improved tumor antigen-specific T-cell responses were observed following the combined therapy. Supported by relevant immunological changes and as a proof of concept for the design of more effective therapeutic regimens, we found that local delivery of VSVΔ51 encoded with IL-12 or with other transgenes in combination with VS further improved therapeutic outcomes in a syngeneic CT26WT colon cancer model. We found that CD8+ T cells and Natural Killer (NK) cells play significant roles in establishing the therapeutic efficacy that we observed; Furthermore, engineering new and targeted therapeutic platforms to impact the antitumor immune response further improves the therapeutic benefits of the combined therapy.

No description available.

No / Vascular disrupting agents (VDA) offer a strategy to starve solid tumors of nutrients and oxygen concomitant with tumor shrinkage. Several VDAs have progressed into early clinical trials, but their therapeutic value seems to be compromised by systemic toxicity. In this report, we describe the design and characterization of a novel VDA, ICT2588, that is nontoxic until activated specifically in the tumor by membrane-type 1 matrix metalloproteinase (MT1-MMP). HT1080 cancer cells expressing MT1-MMP were selectively chemosensitive to ICT2588, whereas MCF7 cells that did not express MT1-MMP were nonresponsive. Preferential hydrolysis of ICT2588 to its active metabolite (ICT2552) was observed in tumor homogenates of HT1080 relative to MCF7 homogenates, mouse plasma, and liver homogenate. ICT2588 activation was inhibited by the MMP inhibitor ilomastat. In HT1080 tumor-bearing mice, ICT2588 administration resulted in the formation of the active metabolite, diminution of tumor vasculature, and hemorrhagic necrosis of the tumor. The antitumor activity of ICT2588 was superior to its active metabolite, exhibiting reduced toxicity, improved therapeutic index, enhanced pharmacodynamic effect, and greater efficacy. Coadministration of ICT2588 with doxorubicin resulted in a significant antitumor response (22.6 d growth delay), which was superior to the administration of ICT2588 or doxorubicin as a single agent, including complete tumor regressions. Our findings support the clinical development of ICT2588, which achieves selective VDA targeting based on MT-MMP activation in the tumor microenvironment.

Yes / A range of oxobis(phenyl‐1,3‐butanedione) vanadium(IV) complexes have been successfully synthesized from cheap starting materials and a simple and solvent‐free one‐pot dry‐melt reaction. This direct, straightforward, fast and alternative approach to inorganic synthesis has the potential for a wide range of applications. Analytical studies confirm their successful synthesis, purity and solid‐state coordination, and we report the complexes’ uses as potential drug candidates for the treatment of cancer. After a 24‐hour incubation of A549 lung carcinoma cells with the compounds, they reveal cytotoxicity values 11‐fold greater than cisplatin, and remain non‐toxic towards normal cell types. Additionally, the complexes are stable over a range of physiological pH values and show the potential for interactions with BSA. / University of Bradford. Grant Number: Internal Research Development Fund

Yes / A deactivated alkene precursor (IC50=81 mu M) to the azinomycin epoxide natural product can be bioactivated by several cytochromes P450 (CYP) to generate antiproliferative metabolites with increased potency (IC50=1-30 mu M) in CHOwt cells. CYP1A1 and 3A4 were shown to generate exclusively the unnatural and the natural-configured azinomycin epoxide diastereoisomer respectively, while CYP1B1 produced both epoxides in a 3:1 mixture. The antiproliferative activity is linked to DNA damage as demonstrated using the comet assay.

O Câncer é uma doença responsável pelos maiores índices de morbidade e mortalidade em todo o mundo. A ocorrência do câncer é relacionada com vários fatores, entre eles, ambientais, nutricionais, genéticos, infecções virais e estilo de vida. Devido a complexidade da doença, há uma busca incessante em novos tratamentos. Atualmente, os medicamentos conhecidos, além de danificar células anormais prejudicam células saudáveis, o que causa efeitos colaterais e toxicidade. Algumas moléculas, por exemplo peptídeos, possuem a capacidade de interagir com proteínas de membrana de células cancerígenas, atuando diretamente nestas células. Estes peptídeos podem ser obtidos a partir da hidrólise de diferentes fontes de proteínas com a utilização de peptidases de origem microbiana. O objetivo do presente estudo foi produzir e purificar peptidases de dois fungos, Eupenicillium javanicum e Myceliophthora thermophila, realizar ensaios de caracterização bioquímica e eficiência catalítica destas enzimas, aplica las na obtenção de peptídeos bioativos a partir de proteínas do leite, ovo e gelatina, e avaliar a atividade antioxidante (in vitro) e atividade antitumoral (in vitro e in vivo) destes peptídeos. Foram produzidas e purificadas duas peptidases, uma metalopeptidase (E. javanicum) e uma serinopeptidase (M. thermophila), o ensaio de cinética enzimática mostrou maior eficiência catalítica na utilização de substratos com alanina na posição P\'2 e tirosina na posição P\'1 da cadeia polipeptídica, respectivamente para cada uma das enzimas. Os peptídeos, produzidos a partir de caseína, apresentaram maior atividade de sequestro de radicais e de quelar ferro. Peptídeos de soro de leite e gelatina inibiram o crescimento de células tumorais de câncer oral e melanoma (in vitro). Peptídeos de soro de leite produzidos por ambas as peptidases reduziram o volume tumoral (células Cal27) em camundongos imunodepriminidos. Ensaios proteômicos destes tumores, com comparação entre grupos tratados e sem tratamento, mostraram que algumas vias envolvidas com a apoptose podem estar envolvidas na redução do volume dos tumores do camundongos tratados com peptídeos obtidos de soro de leite / The cancer is a disease responsible to the higher levels of mortality and morbity around the world. This disease is related to many factors, as environment, nutrition, genetic, virus infection and life style.The complexity of this disease increases the research of new treatments. Currently, the medicines damage both, normal and cancer cells, it promotes side effects and toxicity. Some molecules present specificity and bind to proteins from membranes of cancer cells, some examples are peptides. Peptides can be obtained from proteins by hydrolisys with microrbial proteases. The aim of this study was to produce and purify two proteases from fungi, Eupenicillium javanicum and Myceliophthora thermophila. Biochemical characterization and kinetic assays of these enzymes were evaluated. And then, the proteases were applied on obtention of peptides from milk, egg and gelatin proteins, and the antioxidant (in vitro) and antitumoral activity (in vitro e in vivo) of these peptides were evaluated. The purified enzymes belong to metalo (E. javanicum) and serine (M. thermophila) protease classes, the kinetic assay showed higher catalytic efficiency with tyrosine at P\'1 position and alanine at P\'2 position of polypeptide chain of substrate, to metalo and serine protease, respectively. The peptides from casein presented capacity to scavenge free radicals and to quelate iron. Peptides derived from whey and gelatin inhibited the grown of oral cancer and melanoma cells (in vitro). Peptides obtained from whey decreased the tumor volume of immunosupressed mice. Proteomic assays of these tumors, when compared treatment and control group, showed that peptides can be envolved in some apoptosys pathway and it influences the tumor volume, cosequently, it is decreased on treatment with peptides derived from milk whey

O número de casos de câncer tem aumentado significativamente em todo o mundo, principalmente a partir do século passado. Dessa forma, a busca por novas moléculas capazes de combater esta doença é cada vez maior, visto que muitos fármacos utilizados na terapêutica mostram-se tóxicos e pouco seletivos para células tumorais, causando efeitos adversos que muitas vezes alteram a qualidade de vida do paciente drasticamente. Muitos fármacos antineoplásicos tiveram sua origem relacionada aos produtos naturais. A capsaicina é o principal componente pungente das pimentas vermelhas do gênero Capsicum, e seu efeito antitumoral é extensivamente discutido devido a sua capacidade de induzir apoptose seletivamente em diferentes linhagens de células cancerígenas. Este trabalho teve como objetivo utilizar a estratégia de modificação molecular para o planejamento racional de análogos funcionais da capsaicina, visando à obtenção de moléculas com atividade citotóxica superior. Os análogos foram sintetizados utilizando reações de uma única etapa baseadas em metodologias clássicas de acilação e caracterizados através de metodologias analíticas como espectroscopia de RMN de 1H e 13C, análise elementar e ponto de fusão. Posteriormente, foram avaliadas as atividades biológicas contra quatro linhagens tumorais (PC3, MACL-1, H1299, U138MG) e fibroblastos (3T3), utilizando o método de redução do MTT 3-(4,5-dimetil-tiazol-2-il)-2,5-difeniltetrazólio. Três compostos (RPF306, 452 e 404) inibiram seletivamente o crescimento celular na faixa de concentração de micromolar (µM). Estudos teóricos adicionais revelaram que propriedades topológicas e eletrônicas influenciaram na discriminação de amostras e podem ser importantes no processo de reconhecimento molecular e, subsequentemente, na resposta biológica. Tais resultados indicam que amidas e ésteres aromáticos, como o RPF306 e 404 podem ser modelos interessantes para o planejamento de novas séries de moléculas seletivas e pouco tóxicas, que representem uma alternativa interessante no tratamento do câncer. / Over the past century, the number of cancer cases has increased significantly worldwide. Therefore, the quest for discovery of new molecules able to treat the disease is increasing, since many drugs used in therapy are poorly selective and toxic to normal cells, causing adverse effects that often change dramatically the patient\'s quality of life. Many chemotherapeutic agents had its origin related to natural products. Capsaicin is the main component of pungent red peppers of the genus Capsicum, and its antitumor effect is extensively discussed, due to its ability to selectively induce apoptosis in several cancer cell lines. In this context, our research aims to use the strategy of molecular modification to the rational design of capsaicin functional analogues, in order to obtain molecules with superior cytotoxic activity. The analogues were synthesized using an one-step reaction, based on classical acylation methods and characterized by analytical methods such as 1H and 13C NMR spectroscopy, elemental analysis and melting point. Subsequently, their cytotoxicity were evaluated against four human cancer cell lines (PC3, MACL-1, H1299 and U138MG) and fibroblast (3T3) using the MTT - 3-(4,5 dimethyl thiazole-2-yl)-2,5 diphenyltetrazolium assay. Three compounds (RPF306, 452 and 404) selectively inhibited the growth of cancer cell lines at micromolar (µM) range. In silico studies revealed that topological and electronic properties mostly influenced the samples discrimination and also might be important for the molecular recognition process and, subsequently, biological response or function. The results indicate that aryl amides and esters, such as RPF306 and 404 might be interesting scaffolds to develop a novel series of compounds with higher selective and low toxicity that could represent an alternative in the treatment of cancer.